Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling.
Yu-Chieh TsaiTzu-Yin WangChia-Lang HsuWei-Chou LinJyun-Yu ChenJia-Hua LiYeong-Shiau PuAnn-Lii ChengJason Chia-Hsien ChengSheng-Fang SuPublished in: British journal of cancer (2023)
Unlike pan-HDACi, the selective HDAC6i can enhance BC radiosensitization and effectively inhibit RT-induced oncogenic CXCL1-Snail-signalling, thus further advancing its therapeutic potential with RT.